Navigation Links
Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society
Date:7/23/2009

MUNDELEIN, Ill., July 23 /PRNewswire/ -- Sysmex today announced its customer appreciation dinner fundraiser for the Illinois Chapter of The Leukemia & Lymphoma Society (LLS) has resulted in a combined company/customer donation of $20,000 for LLS. Monies will be directed toward a general fund which supports blood cancer research and patient services. The Sysmex customer appreciation dinner fundraiser was held during the American Association of Clinical Chemistry's (AACC) annual meeting in Chicago July 19 - 23. The fundraising event for LLS corresponds with the state location of Sysmex's headquarters for the Americas and with the location of the 2009 AACC meeting. The Leukemia & Lymphoma Society is the world's largest voluntary health agency dedicated to blood cancer.

"On behalf of Sysmex, our board of directors and our employees, we want to thank our customers for their generosity in joining us in our efforts to support the Leukemia & Lymphoma Society as they work to eradicate hematological cancers. I trust our joint donation will be especially meaningful to the organization in these challenging economic times. We are all honored to have been given the opportunity to help," said John Kershaw, CEO, Sysmex America, Inc.

"The Leukemia & Lymphoma Society is proud to partner with Sysmex, and honored to be the beneficiary of their generosity," stated Pam Swenk, Executive Director, Illinois Chapter of The Leukemia & Lymphoma Society. "It is somehow appropriate that the global leader in healthcare testing equipment and technology be paired with the leader in the fight against blood cancer to meet the mission of the LLS. Our heartfelt thanks go to Mr. Kershaw and Sysmex."

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sysmex America Debuts High-end Sample Management System During AACC
2. Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems
3. Sysmex America Names Industry Veteran to Business Development Post
4. Sysmex America Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
5. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
6. BioReference Laboratories Partners With Sysmex America
7. Siemens and Sysmex Renew Global Agreement
8. Sysmex Corporation Announces Organizational Changes
9. Sysmex America Introduces On Demand Middleware Training Tool
10. Sysmex Customer Satisfaction Ranks Highest in Independent Market Research
11. Sysmex America to Release e-Verify(TM), Powered By SNCS(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: